Shopping Cart 0
Cart Subtotal
USD 0

North America Bio-implants Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 3200
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

North America bio-implants market is expected to reach USD 139,281.02 million by 2025, from USD 79,384.99 million in 2017 growing at a CAGR of 7.4% in the forecast period 2018 to 2025.

The major factors driving the growth of this market are rising number of aging and geriatric population, changing lifestyle problems, rising incidence of chronic diseases, increasing awareness about cosmetic implants, technological advancement in implants, rising demand for non-surgical bio-implants are the factors which is driving the growth of the market.

The key market players for North America Bio-Implants Market are listed below:

Abbott Laboratories

Medtronic

Boston Scientific Corporation

Bio-Rad Laboratories, Inc.

Somnomed Limited

Johnson & Johnson Services, Inc.

Edwards Lifesciences Corporation

F. Hoffmann-La Roche AG

C.R. Bard, Inc.

Mimedx Group, Inc.

Biotronik Se & Co.Kg

The market is further segmented into:

Product Type

Type

Material

Mode of Administration

End-user

The North America bio-implants market is segmented based on product type into orthopedics & trauma, pacing devices, stents & related implants, spinal implants, ophthalmic implants, structural cardiac implants, dental implants, neurostimulators implants, prosthetic implants, and others. In 2018, orthopedics and trauma segment is expected to dominate the North America bio-implants market with 24.4% market share and is expected to reach USD 35,722.74 million by 2025, growing at the highest CAGR of 8.2% in the forecast period 2018 to 2025.

The North America bio-implants market is segmented on the basis of type into allograft, autograft, xenograft, synthetic, and others. In 2018, Allograft segment is expected to dominate the North America bio-implants market with 42.7% market share and is expected to reach USD 60,930.2 million by 2025, growing at the highest CAGR of 7.8% in the forecast period 2018 to 2025.

The North America bio-implants market is segmented on the basis of material into biomaterial metal, alloy, polymers, ceramics, and acrylic hydrogel. In 2018, Biomaterial Metal segment is expected to dominate the North America bio-implants market with 30.9% market share and is expected to reach USD 43,082.31 million by 2025, growing at CAGR of 7.4%in the forecast period 2018 to 2025. However, Alloy is expected to grow at the highest CAGR of 8.0% in the forecast period, and is expected to reach USD 38,891.78 million in 2025 from USD 21,167.45 million in 2017.

The North America bio-implants market is segmented on the basis of mode of administration into surgical and non-surgical. In 2018, surgical segment is expected to dominate the North America bio-implants market with 60.4% market share and is expected to reach USD 82,434.84 million by 2025, growing at CAGR of 7.1% in the forecast period 2018 to 2025. However, Non-surgical is expected to grow at the highest CAGR of 7.9% in the forecast period, and is expected to reach USD 56,846.18 million in 2025 from USD 31,256.09 million in 2017.

The North America bio-implants market is segmented on the basis of end users into hospitals, ambulatory surgical centers, clinics, and others. In 2018, Hospital segment is expected to dominate the North America bio-implants market with 45.7% market share and is expected to reach USD 64,636.65 million by 2025, growing at the highest CAGR of 7.6% in the forecast period 2018 to 2025.

Based on geography, the North America bio-implants market is segmented into geographical regions, such as,

U.S.

Canada

Mexico

Covered in this report

The report covers the present scenario and the growth prospects of the North America bio-implants market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

READ MORE

Table Of Content

Scope

Table Of Contents

1. Introduction 68

1.1. Objectives Of The Study 68

1.2. Market Definition 68

1.3. Overview Of North America Bio-Implants Market 68

1.4. Currency And Pricing 70

1.5. Limitation 70

1.6. Markets Covered 71

2. Market Segmentation 75

2.1. Markets Covered 75

2.2. Geographic Scope 76

2.3. Years Considered For The Study 77

2.4. Currency And Pricing 77

2.5. Research Methodology 78

2.6. Primary Interviews With Key Opinion Leaders 81

2.7. Secondary Sources 82

2.8. Assumptions 82

3. Market Overview 83

3.1. Drivers 85

3.1.1. Rising Number Of Aging And Geriatric Population 85

3.1.2. Changing Lifestyle Problems 85

3.1.3. Rising Incidence Of Chronic Diseases 86

3.1.4. Increasing Awareness About Cosmetic Implants 87

3.1.5. Technological Advancement In Implants 88

3.1.6. Rising Demand For Non-Surgical Bio-Implants 88

3.2. Restraints 89

3.2.1. High Cost Of Implants 89

3.2.2. Regulatory Scenario 89

3.2.3. Unfavourable Reimbursement Policies 90

3.3. Opportunities 91

3.3.1. Emerging Inclination For Mis Surgeries 91

3.3.2. Growing Number Of Diagnostic Centers And Clinics 92

3.3.3. Emerging Countries 92

3.3.4. Rising Medical Tourism 93

3.4. Challenges 94

3.4.1. Side-Effects Of Various Cosmetic Surgery 94

3.4.2. Lack Of Trained Professionals 94

4. Executive Summary 95

5. Premium Insights 99

6. North America Bio-Implants Market, By Product Type 101

6.1. Overview 102

6.2. Orthopedics & Trauma 104

6.2.1. Reconstructive Joint Replacements 106

6.2.1.1. Knee Replacement Implants 106

6.2.1.2. Hip Replacement Implants 106

6.2.1.3. Extremities 107

6.2.2. Orthobiologics 109

6.2.2.1. Hyaluronic Acid 109

6.2.2.2. Bone Substitutes 110

6.2.2.3. Bone Growth Factors 110

6.2.2.4. Tissue Implants 110

6.2.2.5. Bone Cement 110

6.2.3. Trauma Implants 111

6.2.3.1. Internal Trauma Fixation Devices 111

6.2.3.2. Craniomaxillofacial Fixation Devices 111

6.2.3.3. Implantable Trauma Stimulators 112

6.2.4. Sports Medicine 112

6.3. Pacing Devices 112

6.3.1. Cardiac Resynchronization Therapy Devices (Crtd) 113

6.3.2. Implantable Cardioverter Defibrillators (Icd) 114

6.3.3. Implantable Cardiac Pacemakers (Icp) 114

6.3.3.1. Single Chambered 115

6.3.3.2. Dual Chambered 115

6.3.3.3. Multiple Chambered 115

6.3.4. Pacing Accessories 115

6.3.4.1. Pacing Leads 116

6.3.4.2. Pacing Batteries 116

6.4. Stents & Related Implants 116

6.4.1. Coronary Stents 118

6.4.1.1. Drug-Eluting Stents 118

6.4.1.2. Bare-Metal Coronary Stents 119

6.4.1.3. Bioabsorbable Stents 119

6.4.2. Peripheral Stents 119

6.4.2.1. Endovascular Stent-Grafts 120

6.4.2.2. Renal & Related Stents 120

6.4.2.3. Femoral & Related Stents 120

6.4.2.4. Carotid Stents 120

6.4.3. Stent-Related Implants 121

6.4.3.1. Synthetic Grafts 121

6.4.3.2. Vascular Grafts 122

6.4.3.3. Peripheral Grafts 122

6.4.3.4. Vena Cava Filters 122

6.5. Spinal Implants 123

6.5.1. Thoracolumbar Implants 124

6.5.2. Intervertebral Spacers 124

6.5.3. Machined Allograft Spacers 125

6.5.4. Cervical Implants 125

6.5.5. Motion Preservation Implants 125

6.5.6. Implantable Spinal Stimulators 125

6.6. Ophthalmic Implants 125

6.6.1. Intraocular Lens 127

6.6.2. Glaucoma & Other Lenses 127

6.7. Structural Cardiac Implants 127

6.7.1. Heart Valves & Accessories 129

6.7.2. Tissue Heart Valves 129

6.7.3. Mechanical Heart Valves 129

6.7.4. Heart Valve Repair Devices 129

6.7.5. Ventricular Assist Device (Vad) 129

6.7.6. Implantable Heart Monitors 130

6.7.7. Insertable Loop Recorders (Ilrs) 130

6.7.8. Implantable Hemodynamic Monitors (Ihm) 130

6.8. Dental Implants 131

6.8.1. Plate Form Dental Implants 132

6.8.2. Root Form Dental Implants 132

6.9. Neurostimulators Implants 133

6.9.1. Cortical Stimulators 134

6.9.2. Deep Brain Stimulators 134

6.9.3. Sacral Nerve Stimulators 134

6.9.4. Spinal Cord Stimulators 135

6.9.5. Vagus Nerve Stimulators 135

6.10. Prosthetic Implants 135

6.10.1. Osseointegration 136

6.10.2. Titanium-Based Prosthetic Implants 136

6.11. Others 137

6.11.1. Gynecological Devices 138

6.11.2. Drug Implants 138

6.11.3. Cosmetic Implants 139

6.11.4. Gastroenterological Implants 139

6.11.5. Urological Implants 139

6.11.6. Skin & Wound Care 139

6.11.7. Otolaryngeal Implants 139

7. North America Bio-Implants Market, By Type 140

7.1. Overview 141

7.2. Allograft 143

7.3. Autograft 144

7.4. Xenograft 145

7.5. Synthetic 146

7.6. Others 147

8. North America Bio-Implants Market, By Material 148

8.1. Overview 149

8.2. Biomaterial Metal 151

8.2.1. Titanium 152

8.2.2. Gold 152

8.2.3. Silver 152

8.2.4. Platinum 153

8.3. Alloy 153

8.4. Polymer 154

8.4.1. Natural Polymers 155

8.4.2. Synthetic Polymers 155

8.5. Ceramics 156

8.6. Acrylic Hydrogel 157

9. North America Bio-Implants Market, Mode Of Administration 158

9.1. Overview 159

9.2. Surgical 161

9.3. Non-Surgical 162

9.3.1. Injectable Fillers/Biomaterials 163

9.3.2. Osteogenic Injectable Bone Substitutes 163

9.3.3. Viscosupplementation 164

9.3.4. Viscoaugmentation 164

10. North America Bio-Implants Market, By End-User 165

10.1. Overview 166

10.2. Clinics 168

10.3. Hospitals 169

10.4. Ambulatory Surgical Centers 170

10.5. Others 171

11. North America Bio-Implants Market, By Geography 172

11.1. North America 173

11.1.1. U.S. 195

11.1.2. Canada 210

11.1.3. Mexico 225

12. North America Bio-Implants Market, Company Landscape 240

12.1. Company Share Analysis: North America 240

13. Company Profiles 241

13.1. Medtronic 241

13.1.1. Company Overview 241

13.1.2. Revenue Analysis 242

13.1.3. Product Portfolio 243

13.1.4. Recent Developments 244

13.2. Johnson & Johnson Services, Inc. 245

13.2.1. Company Overview 245

13.2.2. Johnson & Johnson Services, Inc.: Revenue Analysis 245

13.2.3. Product Portfolio 246

13.2.4. Recent Developments 246

13.3. Edward Lifesciences Corporation 247

13.3.1. Company Overview 247

13.3.2. Edward Lifesciences Corporation :Revenue Analysis 247

13.3.3. Product Portfolio 248

13.3.4. Recent Developments 248

13.4. Boston Scientific Corporation 249

13.4.1. Company Overview 249

13.4.2. Boston Scientific Corporation: Revenue Analysis 249

13.4.3. Product Portfolio 250

13.4.4. Recent Developments 250

13.5. Integra Lifesciences Corporation 251

13.5.1. Company Overview 251

13.5.2. Integra Lifesciences Corporation :Revenue Analysis 251

13.5.3. Product Portfolio 252

13.5.4. Recent Developments 252

13.6. Abbott 253

13.6.1. Company Overview 253

13.6.2. Abbott :Revenue Analysis 253

13.6.3. Product Portfolio 254

13.6.4. Recent Developments 254

13.7. C. R. Bard, Inc. 255

13.7.1. Company Overview 255

13.7.2. C. R. Bard, Inc.:Revenue Analysis 255

13.7.3. Product Portfolio 256

13.7.4. Recent Developments 256

13.8. Zimmer Biomet 257

13.8.1. Company Overview 257

13.8.2. Zimmer Biomet :Revenue Analysis 257

13.8.3. Product Portfolio 258

13.8.4. Recent Developments 258

13.9. Biotronik Se & Co. Kg 259

13.9.1. Company Overview 259

13.9.2. Biotronik Se & Co. Kg :Company Snapshot 259

13.9.3. Product Portfolio 260

13.9.4. Recent Developments 260

13.10. Lifenet Health, Inc. 261

13.10.1. Company Overview 261

13.10.2. Lifenet Health, Inc.:Company Snapshot 261

13.10.3. Product Portfolio 262

13.10.4. Recent Developments 262

13.11. Integrated Orbital Implants 263

13.11.1. Company Overview 263

13.11.2. Integrated Orbital Implants :Company Snapshot 263

13.11.3. Product Portfolio 264

13.11.4. Recent Developments 264

13.12. Smith & Nephew 265

13.12.1. Company Overview 265

13.12.2. Smith & Nephew :Revenue Analysis 265

13.12.3. Product Portfolio 266

13.12.4. Recent Developments 267

13.13. Stryker 268

13.13.1. Company Overview 268

13.13.2. Stryker :Revenue Analysis 268

13.13.3. Product Portfolio 269

13.13.4. Recent Developments 269

13.14. W. L. Gore & Associates, Inc 270

13.14.1. Company Overview 270

13.14.2. W. L. Gore & Associates, Inc :Company Snapshot 270

13.14.3. Product Portfolio 271

13.14.4. Recent Developments 271

13.15. Valeant Pharmaceuticals International Inc. 272

13.15.1. Company Overview 272

13.15.2. Valeant Pharmaceuticals International Inc.:Revenue Analysis 272

13.15.3. Product Portfolio 273

13.15.4. Recent Developments 273

13.16. Somnomed 274

13.16.1. Company Overview 274

13.16.2. Somnomed :Revenue Analysis 274

13.16.3. Product Portfolio 275

13.16.4. Recent Developments 275

13.17. Wright Medical Group N.V. 276

13.17.1. Company Overview 276

13.17.2. Wright Medical Group N.V.:Revenue Analysis 276

13.17.3. Product Portfolio 277

13.17.4. Recent Developments 277

13.18. Livanova Plc 278

13.18.1. Company Overview 278

13.18.2. Livanova Plc :Revenue Analysis 278

13.18.3. Product Portfolio 279

13.18.4. Recent Developments 279

13.19. St. Jude Medical, Inc. (A Subsidiary Of Abbott) 280

13.19.1. Company Overview 280

13.19.2. St. Jude Medical, Inc.:Company Snapshot 280

13.19.3. Product Portfolio 281

13.19.4. Recent Developments 281

13.20. Mimedx Group, Inc. 282

13.20.1. Company Overview 282

13.20.2. Mimedx Group, Inc.:Revenue Analysis 282

13.20.3. Product Portfolio 283

13.20.4. Recent Developments 283

13.21. Cook Group 284

13.21.1. Company Overview 284

13.21.2. Cook Group :Company Snapshot 284

13.21.3. Product Portfolio 284

13.21.4. Recent Developments 284

14. Related Reports 285


List Of Figure

Figures List

Figure 1 North America Bio-Implants Market : Segmentation 33

Figure 2 North America Bio-Implants Market: Data Triangulation 36

Figure 3 North America Bio-Implants Market: Research Snapshot 37

Figure 4 North America Bio-Implants Market : Bottom Up Approach 38

Figure 5 North America Bio-Implants Market : Top Down Approach 38

Figure 6 North America Bio-Implants Market: Interview Demographics 39

Figure 7 Drivers, Restraints, Opportunities, And Challenges Of North America Bio-Implants Market 42

Figure 8 Number Of Cosmetic Surgeries Performed In 2000, 2015, And 2016 In U.S. 45

Figure 9 North America Bio-Implants Market: Segmentation 55

Figure 10 North America Is Expected To Dominate The Market For Bio-Implants And Asia Pacific Is Expected To Be Growing With The Highest Cagr In The Forecast Period From 2018 To 2025 56

Figure 11 Rising Number Of Aging And Geriatric Population, And Increased Incidences Of Chronic Diseases Are Expected To Drive The Market For Bio-Implants In The Forecast Period 2018 To 2025 57

Figure 12 Orthopedics & Trauma Segment Is Expected To Account For The Largest Share Of The North America Bio-Implants Market In 2018 & 2025 58

Figure 13 North America Bio-Implants Market: By Product Type, 2017 60

Figure 14 North America Bio-Implants Market: By Type, 2017 99

Figure 15 North America Bio-Implants Market: By Material, 2017 107

Figure 16 North America Bio-Implants Market: By Mode Of Administration, 2017 117

Figure 17 North America Bio-Implants Market: By End-User, 2017 124

Figure 18 North America Bio-Implants Market : Snapshot (2017) 132

Figure 19 North America Bio-Implants Market: By Country (2017) 133

Figure 20 North America Bio-Implants Market: By Country (2018 & 2025) 134

Figure 21 North America Bio-Implants Market, By Country (2017 & 2025) 135

Figure 22 North America Bio-Implants Market, By Product Type (2018 & 2025) 136

Figure 23 North America Bio-Implants Market: Company Share 2017 (%) 198


List Of Table

TABLE 1 TOTAL NUMBER OF ED VISITS (2011-2014) 51

TABLE 2 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC 52

TABLE 3 NORTH AMERICA BIO-IMPLANTS MARKET, BY PRODUCT TYPE, 2016- 2025 (USD MILLION) 62

TABLE 4 NORTH AMERICA BIO IMPLANT MARKET, ORTHOPEDICS & TRAUMA, BY REGION, 2016-2025 (USD MILLION) 63

TABLE 5 NORTH AMERICA BIO-IMPLANTS MARKET, ORTHOPEDICS & TRAUMA, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 64

TABLE 6 NORTH AMERICA BIO-IMPLANTS MARKET, RECONSTRUCTIVE JOINT REPLACEMENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 65

TABLE 7 NORTH AMERICA BIO-IMPLANTS MARKET, EXTREMITIES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 66

TABLE 8 NORTH AMERICA BIO-IMPLANTS MARKET, ORTHOBIOLOGICS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 68

TABLE 9 NORTH AMERICA BIO-IMPLANTS MARKET, TRAUMA IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 70

TABLE 10 NORTH AMERICA BIO IMPLANT MARKET, PACING DEVICES, BY REGION, 2016-2025 (USD MILLION) 71

TABLE 11 NORTH AMERICA BIO-IMPLANTS MARKET, PACING DEVICES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 72

TABLE 12 NORTH AMERICA BIO-IMPLANTS MARKET, IMPLANTABLE CARDIAC PACEMAKERS (ICPS), BY PRODUCT TYPE, 2016-2025 (USD MILLION) 73

TABLE 13 NORTH AMERICA BIO-IMPLANTS MARKET, PACING ACCESSORIES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 74

TABLE 14 NORTH AMERICA BIO IMPLANT MARKET, STENTS & RELATED IMPLANTS, BY REGION, 2016-2025 (USD MILLION) 75

TABLE 15 NORTH AMERICA BIO-IMPLANTS MARKET, STENTS & RELATED IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 76

TABLE 16 NORTH AMERICA BIO-IMPLANTS MARKET, CORONARY STENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 77

TABLE 17 NORTH AMERICA BIO-IMPLANTS MARKET, PERIPHERAL STENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 78

TABLE 18 NORTH AMERICA BIO-IMPLANTS MARKET, STENT-RELATED IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 80

TABLE 19 NORTH AMERICA BIO IMPLANT MARKET, SPINAL IMPLANTS, BY REGION, 2016-2025 (USD MILLION) 82

TABLE 20 NORTH AMERICA BIO-IMPLANTS MARKET, SPINAL IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 83

TABLE 21 NORTH AMERICA BIO IMPLANT MARKET, OPHTHALMIC IMPLANTS, BY REGION, 2016-2025 (USD MILLION) 85

TABLE 22 NORTH AMERICA BIO-IMPLANTS MARKET, OPHTHALMIC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 85

TABLE 23 NORTH AMERICA BIO IMPLANT MARKET, STRUCTURAL CARDIAC IMPLANTS, BY REGION, 2016-2025 (USD MILLION) 86

TABLE 24 NORTH AMERICA BIO-IMPLANTS MARKET, STRUCTURAL CARDIAC IMPLANTS,BY PRODUCT TYPE, 2016-2025 (USD MILLION) 87

TABLE 25 NORTH AMERICA BIO IMPLANT MARKET, DENTAL IMPLANTS, BY REGION, 2016-2025 (USD MILLION) 90

TABLE 26 NORTH AMERICA BIO-IMPLANTS MARKET, DENTAL IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 91

TABLE 27 NORTH AMERICA BIO IMPLANT MARKET, NEUROSTIMULATORS IMPLANTS, BY REGION, 2016-2025 (USD MILLION) 92

TABLE 28 NORTH AMERICA BIO-IMPLANTS MARKET, NEUROSTIMULATORS IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 93

TABLE 29 NORTH AMERICA BIO IMPLANT MARKET, PROSTHETIC IMPLANTS, BY REGION, 2016-2025 (USD MILLION) 94

TABLE 30 NORTH AMERICA BIO-IMPLANTS MARKET, PROSTHETIC IMPLANTS,, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 95

TABLE 31 NORTH AMERICA BIO IMPLANT MARKET, OTHERS, BY REGION, 2016-2025 (USD MILLION) 96

TABLE 32 NORTH AMERICA BIO-IMPLANTS MARKET, OTHERS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 97

TABLE 33 NORTH AMERICA BIO-IMPLANTS MARKET, BY TYPE, 2016 -2025 (USD MILLION) 101

TABLE 34 NORTH AMERICA BIO IMPLANT MARKET, ALLOGRAFT, BY REGION, 2016-2025 (USD MILLION) 102

TABLE 35 NORTH AMERICA BIO IMPLANT MARKET, AUTOGRAFT, BY REGION, 2016 -2025 (USD MILLION) 103

TABLE 36 NORTH AMERICA BIO IMPLANT MARKET, XENOGRAFT, BY REGION, 2016-2025, (USD MILLION) 104

TABLE 37 NORTH AMERICA BIO IMPLANT MARKET, SYNTHETIC, BY REGION, 2016-2015(USD MILLION) 105

TABLE 38 NORTH AMERICA BIO IMPLANT MARKET, OTHERS, BY REGION, 2016-2025 (USD MILLION) 106

TABLE 39 NORTH AMERICA BIO-IMPLANTS MARKET, BY MATERIAL, 2016-2025 (USD MILLION) 109

TABLE 40 NORTH AMERICA BIO IMPLANT MARKET, BIOMATERIAL METAL, BY REGION, 2016-2025 (USD MILLION) 110

TABLE 41 NORTH AMERICA BIO-IMPLANTS MARKET, BIOMATERIAL METAL, BY TYPE2016-2025 (USD MILLION) 111

TABLE 42 NORTH AMERICA BIO IMPLANT MARKET, ALLOY, BY REGION 2016-2025, (USD MILLION) 112

TABLE 43 NORTH AMERICA BIO IMPLANT MARKET, POLYMER, BY REGION 2016-2025, (USD MILLION) 113

TABLE 44 NORTH AMERICA BIO-IMPLANTS MARKET, POLYMERS, BY TYPE, 2016-2025 (USD MILLION) 114

TABLE 45 NORTH AMERICA BIO IMPLANT MARKET, CERAMICS, BY REGION 2016-2025, (USD MILLION) 115

TABLE 46 NORTH AMERICA BIO IMPLANT MARKET, ACRYLIC HYDROGEL, BY REGION, 2016-2025, (USD MILLION) 116

TABLE 47 NORTH AMERICA BIO-IMPLANTS MARKET, BY MODE OF ADMINISTRATION, 2016-2025 (USD MILLION) 119

TABLE 48 NORTH AMERICA BIO IMPLANT MARKET, SURGICAL, BY REGION, 2016-2025 (USD MILLION) 120

TABLE 49 NORTH AMERICA BIO IMPLANT MARKET, NON-SURGICAL, BY REGION, 2016-2025 (USD MILLION) 121

TABLE 50 NORTH AMERICA BIO-IMPLANTS MARKET, NON-SURGICAL, BY MODE OF ADMINISTRATION, 2016-2025 (USD MILLION) 122

TABLE 51 NORTH AMERICA BIO-IMPLANTS MARKET, BY END-USER, 2016-2025 (USD MILLION) 126

TABLE 52 NORTH AMERICA BIO IMPLANT MARKET, CLINICS, BY REGION, 2016-2025 (USD MILLION) 127

TABLE 53 NORTH AMERICA BIO IMPLANT MARKET, HOSPITALS, BY REGION, 2016-2025 (USD MILLION) 128

TABLE 54 NORTH AMERICA BIO IMPLANT MARKET, AMBULATORY SURGICAL CENTERS, BY REGION, 2016-2025 (USD MILLION) 129

TABLE 55 NORTH AMERICA BIO IMPLANT MARKET, OTHERS, BY REGION, 2016-2025 (USD MILLION) 130

TABLE 56 NORTH AMERICA BIO-IMPLANTS MARKET, BY COUNTRY, 2016-2025 (USD MILLION) 138

TABLE 57 NORTH AMERICA BIO-IMPLANTS MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 139

TABLE 58 NORTH AMERICA BIO-IMPLANTS MARKET, ORTHOPEDICS & TRAUMA, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 140

TABLE 59 NORTH AMERICA BIO-IMPLANTS MARKET, RECONSTRUCTIVE JOINT REPLACEMENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 140

TABLE 60 NORTH AMERICA BIO-IMPLANTS MARKET, EXTREMITIES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 141

TABLE 61 NORTH AMERICA BIO-IMPLANTS MARKET, ORTHOBIOLOGICS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 141

TABLE 62 NORTH AMERICA BIO-IMPLANTS MARKET, TRAUMA IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 142

TABLE 63 NORTH AMERICA BIO-IMPLANTS MARKET, PACING DEVICES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 142

TABLE 64 NORTH AMERICA BIO-IMPLANTS MARKET, IMPLANTABLE CARDIAC PACEMAKERS (ICPS), BY PRODUCT TYPE, 2016-2025 (USD MILLION) 143

TABLE 65 NORTH AMERICA BIO-IMPLANTS MARKET, PACING ACCESSORIES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 143

TABLE 66 NORTH AMERICA BIO-IMPLANTS MARKET, STENTS & RELATED IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 144

TABLE 67 NORTH AMERICA BIO-IMPLANTS MARKET, CORONARY STENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 144

TABLE 68 NORTH AMERICA BIO-IMPLANTS MARKET, PERIPHERAL STENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 145

TABLE 69 NORTH AMERICA BIO-IMPLANTS MARKET, STENT-RELATED IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 145

TABLE 70 NORTH AMERICA BIO-IMPLANTS MARKET, SPINAL IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 146

TABLE 71 NORTH AMERICA BIO-IMPLANTS MARKET, OPHTHALMIC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 146

TABLE 72 NORTH AMERICA BIO-IMPLANTS MARKET, STRUCTURAL CARDIAC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 147

TABLE 73 NORTH AMERICA BIO-IMPLANTS MARKET, DENTAL IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 147

TABLE 74 NORTH AMERICA BIO-IMPLANTS MARKET, NEUROSTIMULATORS IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 148

TABLE 75 NORTH AMERICA BIO-IMPLANTS MARKET, PROSTHETIC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 148

TABLE 76 NORTH AMERICA BIO-IMPLANTS MARKET, OTHERS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 149

TABLE 77 NORTH AMERICA BIO-IMPLANTS MARKET, BY TYPE, 2016-2025 (USD MILLION) 150

TABLE 78 NORTH AMERICA BIO-IMPLANTS MARKET, BY MATERIAL, 2016-2025 (USD MILLION) 150

TABLE 79 NORTH AMERICA BIO-IMPLANTS MARKET, BIOMATERIAL METAL, BY TYPE, 2016-2025 (USD MILLION) 151

TABLE 80 NORTH AMERICA BIO-IMPLANTS MARKET, POLYMERS, BY TYPE, 2016-2025 (USD MILLION) 151

TABLE 81 NORTH AMERICA BIO-IMPLANTS MARKET, BY MODE OF ADMINISTRATION, 2016-2025 (USD MILLION) 152

TABLE 82 NORTH AMERICA BIO-IMPLANTS MARKET, NON-SURGICAL, BY MODE OF ADMINISTRATION, 2016-2025 (USD MILLION) 152

TABLE 83 NORTH AMERICA BIO-IMPLANTS MARKET, BY END USER, 2016-2025 (USD MILLION) 153

TABLE 84 U.S. BIO-IMPLANTS MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 154

TABLE 85 U.S. BIO-IMPLANTS MARKET, ORTHOPEDICS & TRAUMA, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 155

TABLE 86 U.S. BIO-IMPLANTS MARKET, RECONSTRUCTIVE JOINT REPLACEMENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 155

TABLE 87 U.S. BIO-IMPLANTS MARKET, EXTREMITIES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 156

TABLE 88 U.S. BIO-IMPLANTS MARKET, ORTHOBIOLOGICS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 156

TABLE 89 U.S. BIO-IMPLANTS MARKET, TRAUMA IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 157

TABLE 90 U.S. BIO-IMPLANTS MARKET, PACING DEVICES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 157

TABLE 91 U.S. BIO-IMPLANTS MARKET, IMPLANTABLE CARDIAC PACEMAKERS (ICPS), BY PRODUCT TYPE, 2016-2025 (USD MILLION) 158

TABLE 92 U.S. BIO-IMPLANTS MARKET, PACING ACCESSORIES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 158

TABLE 93 U.S. BIO-IMPLANTS MARKET, STENTS & RELATED IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 159

TABLE 94 U.S. BIO-IMPLANTS MARKET, CORONARY STENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 159

TABLE 95 U.S. BIO-IMPLANTS MARKET, PERIPHERAL STENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 160

TABLE 96 U.S. BIO-IMPLANTS MARKET, STENT-RELATED IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 160

TABLE 97 U.S. BIO-IMPLANTS MARKET, SPINAL IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 161

TABLE 98 U.S. BIO-IMPLANTS MARKET, OPHTHALMIC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 161

TABLE 99 U.S. BIO-IMPLANTS MARKET, STRUCTURAL CARDIAC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 162

TABLE 100 U.S. BIO-IMPLANTS MARKET, DENTAL IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 162

TABLE 101 U.S. BIO-IMPLANTS MARKET, NEUROSTIMULATORS IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 163

TABLE 102 U.S. BIO-IMPLANTS MARKET, PROSTHETIC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 163

TABLE 103 U.S. BIO-IMPLANTS MARKET, OTHERS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 164

TABLE 104 U.S. BIO-IMPLANTS MARKET, BY TYPE, 2016-2025 (USD MILLION) 165

TABLE 105 U.S. BIO-IMPLANTS MARKET, BY MATERIAL, 2016-2025 (USD MILLION) 165

TABLE 106 U.S. BIO-IMPLANTS MARKET, BIOMATERIAL METAL, BY TYPE, 2016-2025 (USD MILLION) 166

TABLE 107 U.S. BIO-IMPLANTS MARKET, POLYMERS, BY TYPE, 2016-2025 (USD MILLION) 166

TABLE 108 U.S. BIO-IMPLANTS MARKET, BY MODE OF ADMINISTRATION, 2016-2025 (USD MILLION) 167

TABLE 109 U.S. BIO-IMPLANTS MARKET, NON-SURGICAL, BY MODE OF ADMINISTRATION, 2016-2025 (USD MILLION) 167

TABLE 110 U.S. BIO-IMPLANTS MARKET, BY END USER, 2016-2025 (USD MILLION) 168

TABLE 111 CANADA BIO-IMPLANTS MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 169

TABLE 112 CANADA BIO-IMPLANTS MARKET, ORTHOPEDICS & TRAUMA, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 170

TABLE 113 CANADA BIO-IMPLANTS MARKET, RECONSTRUCTIVE JOINT REPLACEMENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 170

TABLE 114 CANADA BIO-IMPLANTS MARKET, EXTREMITIES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 171

TABLE 115 CANADA BIO-IMPLANTS MARKET, ORTHOBIOLOGICS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 171

TABLE 116 CANADA BIO-IMPLANTS MARKET, TRAUMA IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 172

TABLE 117 CANADA BIO-IMPLANTS MARKET, PACING DEVICES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 172

TABLE 118 CANADA BIO-IMPLANTS MARKET, IMPLANTABLE CARDIAC PACEMAKERS (ICPS), BY PRODUCT TYPE, 2016-2025 (USD MILLION) 173

TABLE 119 CANADA BIO-IMPLANTS MARKET, PACING ACCESSORIES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 173

TABLE 120 CANADA BIO-IMPLANTS MARKET, STENTS & RELATED IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 174

TABLE 121 CANADA BIO-IMPLANTS MARKET, CORONARY STENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 174

TABLE 122 CANADA BIO-IMPLANTS MARKET, PERIPHERAL STENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 175

TABLE 123 CANADA BIO-IMPLANTS MARKET, STENT-RELATED IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 175

TABLE 124 CANADA BIO-IMPLANTS MARKET, SPINAL IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 176

TABLE 125 CANADA BIO-IMPLANTS MARKET, OPHTHALMIC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 176

TABLE 126 CANADA BIO-IMPLANTS MARKET, STRUCTURAL CARDIAC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 177

TABLE 127 CANADA BIO-IMPLANTS MARKET, DENTAL IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 177

TABLE 128 CANADA BIO-IMPLANTS MARKET, NEUROSTIMULATORS IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 178

TABLE 129 CANADA BIO-IMPLANTS MARKET, PROSTHETIC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 178

TABLE 130 CANADA BIO-IMPLANTS MARKET, OTHERS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 179

TABLE 131 CANADA BIO-IMPLANTS MARKET, BY TYPE, 2016-2025 (USD MILLION) 180

TABLE 132 CANADA BIO-IMPLANTS MARKET, BY MATERIAL, 2016-2025 (USD MILLION) 180

TABLE 133 CANADA BIO-IMPLANTS MARKET, BIOMATERIAL METAL, BY TYPE, 2016-2025 (USD MILLION) 181

TABLE 134 CANADA BIO-IMPLANTS MARKET, POLYMERS, BY TYPE, 2016-2025 (USD MILLION) 181

TABLE 135 CANADA BIO-IMPLANTS MARKET, BY MODE OF ADMINISTRATION, 2016-2025 (USD MILLION) 182

TABLE 136 CANADA BIO-IMPLANTS MARKET, NON-SURGICAL, BY MODE OF ADMINISTRATION, 2016-2025 (USD MILLION) 182

TABLE 137 CANADA BIO-IMPLANTS MARKET, BY END USER, 2016-2025 (USD MILLION) 183

TABLE 138 MEXICO BIO-IMPLANTS MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 184

TABLE 139 MEXICO BIO-IMPLANTS MARKET, ORTHOPEDICS & TRAUMA, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 185

TABLE 140 MEXICO BIO-IMPLANTS MARKET, RECONSTRUCTIVE JOINT REPLACEMENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 185

TABLE 141 MEXICO BIO-IMPLANTS MARKET, EXTREMITIES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 186

TABLE 142 MEXICO BIO-IMPLANTS MARKET, ORTHOBIOLOGICS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 186

TABLE 143 MEXICO BIO-IMPLANTS MARKET, TRAUMA IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 187

TABLE 144 MEXICO BIO-IMPLANTS MARKET, PACING DEVICES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 187

TABLE 145 MEXICO BIO-IMPLANTS MARKET, IMPLANTABLE CARDIAC PACEMAKERS (ICPS), BY PRODUCT TYPE, 2016-2025 (USD MILLION) 188

TABLE 146 MEXICO BIO-IMPLANTS MARKET, PACING ACCESSORIES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 188

TABLE 147 MEXICO BIO-IMPLANTS MARKET, STENTS & RELATED IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 189

TABLE 148 MEXICO BIO-IMPLANTS MARKET, CORONARY STENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 189

TABLE 149 MEXICO BIO-IMPLANTS MARKET, PERIPHERAL STENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 190

TABLE 150 MEXICO BIO-IMPLANTS MARKET, STENT-RELATED IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 190

TABLE 151 MEXICO BIO-IMPLANTS MARKET, SPINAL IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 191

TABLE 152 MEXICO BIO-IMPLANTS MARKET, OPHTHALMIC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 191

TABLE 153 MEXICO BIO-IMPLANTS MARKET, STRUCTURAL CARDIAC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 192

TABLE 154 MEXICO BIO-IMPLANTS MARKET, DENTAL IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 192

TABLE 155 MEXICO BIO-IMPLANTS MARKET, NEUROSTIMULATORS IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 193

TABLE 156 MEXICO BIO-IMPLANTS MARKET, PROSTHETIC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 193

TABLE 157 MEXICO BIO-IMPLANTS MARKET, OTHERS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 194

TABLE 158 MEXICO BIO-IMPLANTS MARKET, BY TYPE, 2016-2025 (USD MILLION) 195

TABLE 159 MEXICO BIO-IMPLANTS MARKET, BY MATERIAL, 2016-2025 (USD MILLION) 195

TABLE 160 MEXICO BIO-IMPLANTS MARKET, BIOMATERIAL METAL, BY TYPE, 2016-2025 (USD MILLION) 196

TABLE 161 MEXICO BIO-IMPLANTS MARKET, POLYMERS, BY TYPE, 2016-2025 (USD MILLION) 196

TABLE 162 MEXICO BIO-IMPLANTS MARKET, BY MODE OF ADMINISTRATION, 2016-2025 (USD MILLION) 197

TABLE 163 MEXICO BIO-IMPLANTS MARKET, NON-SURGICAL, BY MODE OF ADMINISTRATION, 2016-2025 (USD MILLION) 197

TABLE 164 MEXICO BIO-IMPLANTS MARKET, BY END USER, 2016-2025 (USD MILLION) 198

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Abbott Laboratories

Medtronic

Boston Scientific Corporation

Bio-Rad Laboratories, Inc.

Somnomed Limited

Johnson & Johnson Services, Inc.

Edwards Lifesciences Corporation

F. Hoffmann-La Roche AG

C.R. Bard, Inc.

Mimedx Group, Inc.

Biotronik Se & Co.Kg

North America bio-implants market is expected to reach USD 139,281.02 million by 2025, from USD 79,384.99 million in 2017 growing at a CAGR of 7.4% in the forecast period 2018 to 2025.

The major factors driving the growth of this market are rising number of aging and geriatric population, changing lifestyle problems, rising incidence of chronic diseases, increasing awareness about cosmetic implants, technological advancement in implants, rising demand for non-surgical bio-implants are the factors which is driving the growth of the market.

The key market players for North America Bio-Implants Market are listed below:

Abbott Laboratories

Medtronic

Boston Scientific Corporation

Bio-Rad Laboratories, Inc.

Somnomed Limited

Johnson & Johnson Services, Inc.

Edwards Lifesciences Corporation

F. Hoffmann-La Roche AG

C.R. Bard, Inc.

Mimedx Group, Inc.

Biotronik Se & Co.Kg

The market is further segmented into:

Product Type

Type

Material

Mode of Administration

End-user

The North America bio-implants market is segmented based on product type into orthopedics & trauma, pacing devices, stents & related implants, spinal implants, ophthalmic implants, structural cardiac implants, dental implants, neurostimulators implants, prosthetic implants, and others. In 2018, orthopedics and trauma segment is expected to dominate the North America bio-implants market with 24.4% market share and is expected to reach USD 35,722.74 million by 2025, growing at the highest CAGR of 8.2% in the forecast period 2018 to 2025.

The North America bio-implants market is segmented on the basis of type into allograft, autograft, xenograft, synthetic, and others. In 2018, Allograft segment is expected to dominate the North America bio-implants market with 42.7% market share and is expected to reach USD 60,930.2 million by 2025, growing at the highest CAGR of 7.8% in the forecast period 2018 to 2025.

The North America bio-implants market is segmented on the basis of material into biomaterial metal, alloy, polymers, ceramics, and acrylic hydrogel. In 2018, Biomaterial Metal segment is expected to dominate the North America bio-implants market with 30.9% market share and is expected to reach USD 43,082.31 million by 2025, growing at CAGR of 7.4%in the forecast period 2018 to 2025. However, Alloy is expected to grow at the highest CAGR of 8.0% in the forecast period, and is expected to reach USD 38,891.78 million in 2025 from USD 21,167.45 million in 2017.

The North America bio-implants market is segmented on the basis of mode of administration into surgical and non-surgical. In 2018, surgical segment is expected to dominate the North America bio-implants market with 60.4% market share and is expected to reach USD 82,434.84 million by 2025, growing at CAGR of 7.1% in the forecast period 2018 to 2025. However, Non-surgical is expected to grow at the highest CAGR of 7.9% in the forecast period, and is expected to reach USD 56,846.18 million in 2025 from USD 31,256.09 million in 2017.

The North America bio-implants market is segmented on the basis of end users into hospitals, ambulatory surgical centers, clinics, and others. In 2018, Hospital segment is expected to dominate the North America bio-implants market with 45.7% market share and is expected to reach USD 64,636.65 million by 2025, growing at the highest CAGR of 7.6% in the forecast period 2018 to 2025.

Based on geography, the North America bio-implants market is segmented into geographical regions, such as,

U.S.

Canada

Mexico

Covered in this report

The report covers the present scenario and the growth prospects of the North America bio-implants market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

READ MORE

Scope

Table Of Contents

1. Introduction 68

1.1. Objectives Of The Study 68

1.2. Market Definition 68

1.3. Overview Of North America Bio-Implants Market 68

1.4. Currency And Pricing 70

1.5. Limitation 70

1.6. Markets Covered 71

2. Market Segmentation 75

2.1. Markets Covered 75

2.2. Geographic Scope 76

2.3. Years Considered For The Study 77

2.4. Currency And Pricing 77

2.5. Research Methodology 78

2.6. Primary Interviews With Key Opinion Leaders 81

2.7. Secondary Sources 82

2.8. Assumptions 82

3. Market Overview 83

3.1. Drivers 85

3.1.1. Rising Number Of Aging And Geriatric Population 85

3.1.2. Changing Lifestyle Problems 85

3.1.3. Rising Incidence Of Chronic Diseases 86

3.1.4. Increasing Awareness About Cosmetic Implants 87

3.1.5. Technological Advancement In Implants 88

3.1.6. Rising Demand For Non-Surgical Bio-Implants 88

3.2. Restraints 89

3.2.1. High Cost Of Implants 89

3.2.2. Regulatory Scenario 89

3.2.3. Unfavourable Reimbursement Policies 90

3.3. Opportunities 91

3.3.1. Emerging Inclination For Mis Surgeries 91

3.3.2. Growing Number Of Diagnostic Centers And Clinics 92

3.3.3. Emerging Countries 92

3.3.4. Rising Medical Tourism 93

3.4. Challenges 94

3.4.1. Side-Effects Of Various Cosmetic Surgery 94

3.4.2. Lack Of Trained Professionals 94

4. Executive Summary 95

5. Premium Insights 99

6. North America Bio-Implants Market, By Product Type 101

6.1. Overview 102

6.2. Orthopedics & Trauma 104

6.2.1. Reconstructive Joint Replacements 106

6.2.1.1. Knee Replacement Implants 106

6.2.1.2. Hip Replacement Implants 106

6.2.1.3. Extremities 107

6.2.2. Orthobiologics 109

6.2.2.1. Hyaluronic Acid 109

6.2.2.2. Bone Substitutes 110

6.2.2.3. Bone Growth Factors 110

6.2.2.4. Tissue Implants 110

6.2.2.5. Bone Cement 110

6.2.3. Trauma Implants 111

6.2.3.1. Internal Trauma Fixation Devices 111

6.2.3.2. Craniomaxillofacial Fixation Devices 111

6.2.3.3. Implantable Trauma Stimulators 112

6.2.4. Sports Medicine 112

6.3. Pacing Devices 112

6.3.1. Cardiac Resynchronization Therapy Devices (Crtd) 113

6.3.2. Implantable Cardioverter Defibrillators (Icd) 114

6.3.3. Implantable Cardiac Pacemakers (Icp) 114

6.3.3.1. Single Chambered 115

6.3.3.2. Dual Chambered 115

6.3.3.3. Multiple Chambered 115

6.3.4. Pacing Accessories 115

6.3.4.1. Pacing Leads 116

6.3.4.2. Pacing Batteries 116

6.4. Stents & Related Implants 116

6.4.1. Coronary Stents 118

6.4.1.1. Drug-Eluting Stents 118

6.4.1.2. Bare-Metal Coronary Stents 119

6.4.1.3. Bioabsorbable Stents 119

6.4.2. Peripheral Stents 119

6.4.2.1. Endovascular Stent-Grafts 120

6.4.2.2. Renal & Related Stents 120

6.4.2.3. Femoral & Related Stents 120

6.4.2.4. Carotid Stents 120

6.4.3. Stent-Related Implants 121

6.4.3.1. Synthetic Grafts 121

6.4.3.2. Vascular Grafts 122

6.4.3.3. Peripheral Grafts 122

6.4.3.4. Vena Cava Filters 122

6.5. Spinal Implants 123

6.5.1. Thoracolumbar Implants 124

6.5.2. Intervertebral Spacers 124

6.5.3. Machined Allograft Spacers 125

6.5.4. Cervical Implants 125

6.5.5. Motion Preservation Implants 125

6.5.6. Implantable Spinal Stimulators 125

6.6. Ophthalmic Implants 125

6.6.1. Intraocular Lens 127

6.6.2. Glaucoma & Other Lenses 127

6.7. Structural Cardiac Implants 127

6.7.1. Heart Valves & Accessories 129

6.7.2. Tissue Heart Valves 129

6.7.3. Mechanical Heart Valves 129

6.7.4. Heart Valve Repair Devices 129

6.7.5. Ventricular Assist Device (Vad) 129

6.7.6. Implantable Heart Monitors 130

6.7.7. Insertable Loop Recorders (Ilrs) 130

6.7.8. Implantable Hemodynamic Monitors (Ihm) 130

6.8. Dental Implants 131

6.8.1. Plate Form Dental Implants 132

6.8.2. Root Form Dental Implants 132

6.9. Neurostimulators Implants 133

6.9.1. Cortical Stimulators 134

6.9.2. Deep Brain Stimulators 134

6.9.3. Sacral Nerve Stimulators 134

6.9.4. Spinal Cord Stimulators 135

6.9.5. Vagus Nerve Stimulators 135

6.10. Prosthetic Implants 135

6.10.1. Osseointegration 136

6.10.2. Titanium-Based Prosthetic Implants 136

6.11. Others 137

6.11.1. Gynecological Devices 138

6.11.2. Drug Implants 138

6.11.3. Cosmetic Implants 139

6.11.4. Gastroenterological Implants 139

6.11.5. Urological Implants 139

6.11.6. Skin & Wound Care 139

6.11.7. Otolaryngeal Implants 139

7. North America Bio-Implants Market, By Type 140

7.1. Overview 141

7.2. Allograft 143

7.3. Autograft 144

7.4. Xenograft 145

7.5. Synthetic 146

7.6. Others 147

8. North America Bio-Implants Market, By Material 148

8.1. Overview 149

8.2. Biomaterial Metal 151

8.2.1. Titanium 152

8.2.2. Gold 152

8.2.3. Silver 152

8.2.4. Platinum 153

8.3. Alloy 153

8.4. Polymer 154

8.4.1. Natural Polymers 155

8.4.2. Synthetic Polymers 155

8.5. Ceramics 156

8.6. Acrylic Hydrogel 157

9. North America Bio-Implants Market, Mode Of Administration 158

9.1. Overview 159

9.2. Surgical 161

9.3. Non-Surgical 162

9.3.1. Injectable Fillers/Biomaterials 163

9.3.2. Osteogenic Injectable Bone Substitutes 163

9.3.3. Viscosupplementation 164

9.3.4. Viscoaugmentation 164

10. North America Bio-Implants Market, By End-User 165

10.1. Overview 166

10.2. Clinics 168

10.3. Hospitals 169

10.4. Ambulatory Surgical Centers 170

10.5. Others 171

11. North America Bio-Implants Market, By Geography 172

11.1. North America 173

11.1.1. U.S. 195

11.1.2. Canada 210

11.1.3. Mexico 225

12. North America Bio-Implants Market, Company Landscape 240

12.1. Company Share Analysis: North America 240

13. Company Profiles 241

13.1. Medtronic 241

13.1.1. Company Overview 241

13.1.2. Revenue Analysis 242

13.1.3. Product Portfolio 243

13.1.4. Recent Developments 244

13.2. Johnson & Johnson Services, Inc. 245

13.2.1. Company Overview 245

13.2.2. Johnson & Johnson Services, Inc.: Revenue Analysis 245

13.2.3. Product Portfolio 246

13.2.4. Recent Developments 246

13.3. Edward Lifesciences Corporation 247

13.3.1. Company Overview 247

13.3.2. Edward Lifesciences Corporation :Revenue Analysis 247

13.3.3. Product Portfolio 248

13.3.4. Recent Developments 248

13.4. Boston Scientific Corporation 249

13.4.1. Company Overview 249

13.4.2. Boston Scientific Corporation: Revenue Analysis 249

13.4.3. Product Portfolio 250

13.4.4. Recent Developments 250

13.5. Integra Lifesciences Corporation 251

13.5.1. Company Overview 251

13.5.2. Integra Lifesciences Corporation :Revenue Analysis 251

13.5.3. Product Portfolio 252

13.5.4. Recent Developments 252

13.6. Abbott 253

13.6.1. Company Overview 253

13.6.2. Abbott :Revenue Analysis 253

13.6.3. Product Portfolio 254

13.6.4. Recent Developments 254

13.7. C. R. Bard, Inc. 255

13.7.1. Company Overview 255

13.7.2. C. R. Bard, Inc.:Revenue Analysis 255

13.7.3. Product Portfolio 256

13.7.4. Recent Developments 256

13.8. Zimmer Biomet 257

13.8.1. Company Overview 257

13.8.2. Zimmer Biomet :Revenue Analysis 257

13.8.3. Product Portfolio 258

13.8.4. Recent Developments 258

13.9. Biotronik Se & Co. Kg 259

13.9.1. Company Overview 259

13.9.2. Biotronik Se & Co. Kg :Company Snapshot 259

13.9.3. Product Portfolio 260

13.9.4. Recent Developments 260

13.10. Lifenet Health, Inc. 261

13.10.1. Company Overview 261

13.10.2. Lifenet Health, Inc.:Company Snapshot 261

13.10.3. Product Portfolio 262

13.10.4. Recent Developments 262

13.11. Integrated Orbital Implants 263

13.11.1. Company Overview 263

13.11.2. Integrated Orbital Implants :Company Snapshot 263

13.11.3. Product Portfolio 264

13.11.4. Recent Developments 264

13.12. Smith & Nephew 265

13.12.1. Company Overview 265

13.12.2. Smith & Nephew :Revenue Analysis 265

13.12.3. Product Portfolio 266

13.12.4. Recent Developments 267

13.13. Stryker 268

13.13.1. Company Overview 268

13.13.2. Stryker :Revenue Analysis 268

13.13.3. Product Portfolio 269

13.13.4. Recent Developments 269

13.14. W. L. Gore & Associates, Inc 270

13.14.1. Company Overview 270

13.14.2. W. L. Gore & Associates, Inc :Company Snapshot 270

13.14.3. Product Portfolio 271

13.14.4. Recent Developments 271

13.15. Valeant Pharmaceuticals International Inc. 272

13.15.1. Company Overview 272

13.15.2. Valeant Pharmaceuticals International Inc.:Revenue Analysis 272

13.15.3. Product Portfolio 273

13.15.4. Recent Developments 273

13.16. Somnomed 274

13.16.1. Company Overview 274

13.16.2. Somnomed :Revenue Analysis 274

13.16.3. Product Portfolio 275

13.16.4. Recent Developments 275

13.17. Wright Medical Group N.V. 276

13.17.1. Company Overview 276

13.17.2. Wright Medical Group N.V.:Revenue Analysis 276

13.17.3. Product Portfolio 277

13.17.4. Recent Developments 277

13.18. Livanova Plc 278

13.18.1. Company Overview 278

13.18.2. Livanova Plc :Revenue Analysis 278

13.18.3. Product Portfolio 279

13.18.4. Recent Developments 279

13.19. St. Jude Medical, Inc. (A Subsidiary Of Abbott) 280

13.19.1. Company Overview 280

13.19.2. St. Jude Medical, Inc.:Company Snapshot 280

13.19.3. Product Portfolio 281

13.19.4. Recent Developments 281

13.20. Mimedx Group, Inc. 282

13.20.1. Company Overview 282

13.20.2. Mimedx Group, Inc.:Revenue Analysis 282

13.20.3. Product Portfolio 283

13.20.4. Recent Developments 283

13.21. Cook Group 284

13.21.1. Company Overview 284

13.21.2. Cook Group :Company Snapshot 284

13.21.3. Product Portfolio 284

13.21.4. Recent Developments 284

14. Related Reports 285


List Of Figure

Figures List

Figure 1 North America Bio-Implants Market : Segmentation 33

Figure 2 North America Bio-Implants Market: Data Triangulation 36

Figure 3 North America Bio-Implants Market: Research Snapshot 37

Figure 4 North America Bio-Implants Market : Bottom Up Approach 38

Figure 5 North America Bio-Implants Market : Top Down Approach 38

Figure 6 North America Bio-Implants Market: Interview Demographics 39

Figure 7 Drivers, Restraints, Opportunities, And Challenges Of North America Bio-Implants Market 42

Figure 8 Number Of Cosmetic Surgeries Performed In 2000, 2015, And 2016 In U.S. 45

Figure 9 North America Bio-Implants Market: Segmentation 55

Figure 10 North America Is Expected To Dominate The Market For Bio-Implants And Asia Pacific Is Expected To Be Growing With The Highest Cagr In The Forecast Period From 2018 To 2025 56

Figure 11 Rising Number Of Aging And Geriatric Population, And Increased Incidences Of Chronic Diseases Are Expected To Drive The Market For Bio-Implants In The Forecast Period 2018 To 2025 57

Figure 12 Orthopedics & Trauma Segment Is Expected To Account For The Largest Share Of The North America Bio-Implants Market In 2018 & 2025 58

Figure 13 North America Bio-Implants Market: By Product Type, 2017 60

Figure 14 North America Bio-Implants Market: By Type, 2017 99

Figure 15 North America Bio-Implants Market: By Material, 2017 107

Figure 16 North America Bio-Implants Market: By Mode Of Administration, 2017 117

Figure 17 North America Bio-Implants Market: By End-User, 2017 124

Figure 18 North America Bio-Implants Market : Snapshot (2017) 132

Figure 19 North America Bio-Implants Market: By Country (2017) 133

Figure 20 North America Bio-Implants Market: By Country (2018 & 2025) 134

Figure 21 North America Bio-Implants Market, By Country (2017 & 2025) 135

Figure 22 North America Bio-Implants Market, By Product Type (2018 & 2025) 136

Figure 23 North America Bio-Implants Market: Company Share 2017 (%) 198


List Of Table

TABLE 1 TOTAL NUMBER OF ED VISITS (2011-2014) 51

TABLE 2 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC 52

TABLE 3 NORTH AMERICA BIO-IMPLANTS MARKET, BY PRODUCT TYPE, 2016- 2025 (USD MILLION) 62

TABLE 4 NORTH AMERICA BIO IMPLANT MARKET, ORTHOPEDICS & TRAUMA, BY REGION, 2016-2025 (USD MILLION) 63

TABLE 5 NORTH AMERICA BIO-IMPLANTS MARKET, ORTHOPEDICS & TRAUMA, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 64

TABLE 6 NORTH AMERICA BIO-IMPLANTS MARKET, RECONSTRUCTIVE JOINT REPLACEMENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 65

TABLE 7 NORTH AMERICA BIO-IMPLANTS MARKET, EXTREMITIES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 66

TABLE 8 NORTH AMERICA BIO-IMPLANTS MARKET, ORTHOBIOLOGICS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 68

TABLE 9 NORTH AMERICA BIO-IMPLANTS MARKET, TRAUMA IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 70

TABLE 10 NORTH AMERICA BIO IMPLANT MARKET, PACING DEVICES, BY REGION, 2016-2025 (USD MILLION) 71

TABLE 11 NORTH AMERICA BIO-IMPLANTS MARKET, PACING DEVICES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 72

TABLE 12 NORTH AMERICA BIO-IMPLANTS MARKET, IMPLANTABLE CARDIAC PACEMAKERS (ICPS), BY PRODUCT TYPE, 2016-2025 (USD MILLION) 73

TABLE 13 NORTH AMERICA BIO-IMPLANTS MARKET, PACING ACCESSORIES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 74

TABLE 14 NORTH AMERICA BIO IMPLANT MARKET, STENTS & RELATED IMPLANTS, BY REGION, 2016-2025 (USD MILLION) 75

TABLE 15 NORTH AMERICA BIO-IMPLANTS MARKET, STENTS & RELATED IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 76

TABLE 16 NORTH AMERICA BIO-IMPLANTS MARKET, CORONARY STENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 77

TABLE 17 NORTH AMERICA BIO-IMPLANTS MARKET, PERIPHERAL STENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 78

TABLE 18 NORTH AMERICA BIO-IMPLANTS MARKET, STENT-RELATED IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 80

TABLE 19 NORTH AMERICA BIO IMPLANT MARKET, SPINAL IMPLANTS, BY REGION, 2016-2025 (USD MILLION) 82

TABLE 20 NORTH AMERICA BIO-IMPLANTS MARKET, SPINAL IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 83

TABLE 21 NORTH AMERICA BIO IMPLANT MARKET, OPHTHALMIC IMPLANTS, BY REGION, 2016-2025 (USD MILLION) 85

TABLE 22 NORTH AMERICA BIO-IMPLANTS MARKET, OPHTHALMIC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 85

TABLE 23 NORTH AMERICA BIO IMPLANT MARKET, STRUCTURAL CARDIAC IMPLANTS, BY REGION, 2016-2025 (USD MILLION) 86

TABLE 24 NORTH AMERICA BIO-IMPLANTS MARKET, STRUCTURAL CARDIAC IMPLANTS,BY PRODUCT TYPE, 2016-2025 (USD MILLION) 87

TABLE 25 NORTH AMERICA BIO IMPLANT MARKET, DENTAL IMPLANTS, BY REGION, 2016-2025 (USD MILLION) 90

TABLE 26 NORTH AMERICA BIO-IMPLANTS MARKET, DENTAL IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 91

TABLE 27 NORTH AMERICA BIO IMPLANT MARKET, NEUROSTIMULATORS IMPLANTS, BY REGION, 2016-2025 (USD MILLION) 92

TABLE 28 NORTH AMERICA BIO-IMPLANTS MARKET, NEUROSTIMULATORS IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 93

TABLE 29 NORTH AMERICA BIO IMPLANT MARKET, PROSTHETIC IMPLANTS, BY REGION, 2016-2025 (USD MILLION) 94

TABLE 30 NORTH AMERICA BIO-IMPLANTS MARKET, PROSTHETIC IMPLANTS,, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 95

TABLE 31 NORTH AMERICA BIO IMPLANT MARKET, OTHERS, BY REGION, 2016-2025 (USD MILLION) 96

TABLE 32 NORTH AMERICA BIO-IMPLANTS MARKET, OTHERS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 97

TABLE 33 NORTH AMERICA BIO-IMPLANTS MARKET, BY TYPE, 2016 -2025 (USD MILLION) 101

TABLE 34 NORTH AMERICA BIO IMPLANT MARKET, ALLOGRAFT, BY REGION, 2016-2025 (USD MILLION) 102

TABLE 35 NORTH AMERICA BIO IMPLANT MARKET, AUTOGRAFT, BY REGION, 2016 -2025 (USD MILLION) 103

TABLE 36 NORTH AMERICA BIO IMPLANT MARKET, XENOGRAFT, BY REGION, 2016-2025, (USD MILLION) 104

TABLE 37 NORTH AMERICA BIO IMPLANT MARKET, SYNTHETIC, BY REGION, 2016-2015(USD MILLION) 105

TABLE 38 NORTH AMERICA BIO IMPLANT MARKET, OTHERS, BY REGION, 2016-2025 (USD MILLION) 106

TABLE 39 NORTH AMERICA BIO-IMPLANTS MARKET, BY MATERIAL, 2016-2025 (USD MILLION) 109

TABLE 40 NORTH AMERICA BIO IMPLANT MARKET, BIOMATERIAL METAL, BY REGION, 2016-2025 (USD MILLION) 110

TABLE 41 NORTH AMERICA BIO-IMPLANTS MARKET, BIOMATERIAL METAL, BY TYPE2016-2025 (USD MILLION) 111

TABLE 42 NORTH AMERICA BIO IMPLANT MARKET, ALLOY, BY REGION 2016-2025, (USD MILLION) 112

TABLE 43 NORTH AMERICA BIO IMPLANT MARKET, POLYMER, BY REGION 2016-2025, (USD MILLION) 113

TABLE 44 NORTH AMERICA BIO-IMPLANTS MARKET, POLYMERS, BY TYPE, 2016-2025 (USD MILLION) 114

TABLE 45 NORTH AMERICA BIO IMPLANT MARKET, CERAMICS, BY REGION 2016-2025, (USD MILLION) 115

TABLE 46 NORTH AMERICA BIO IMPLANT MARKET, ACRYLIC HYDROGEL, BY REGION, 2016-2025, (USD MILLION) 116

TABLE 47 NORTH AMERICA BIO-IMPLANTS MARKET, BY MODE OF ADMINISTRATION, 2016-2025 (USD MILLION) 119

TABLE 48 NORTH AMERICA BIO IMPLANT MARKET, SURGICAL, BY REGION, 2016-2025 (USD MILLION) 120

TABLE 49 NORTH AMERICA BIO IMPLANT MARKET, NON-SURGICAL, BY REGION, 2016-2025 (USD MILLION) 121

TABLE 50 NORTH AMERICA BIO-IMPLANTS MARKET, NON-SURGICAL, BY MODE OF ADMINISTRATION, 2016-2025 (USD MILLION) 122

TABLE 51 NORTH AMERICA BIO-IMPLANTS MARKET, BY END-USER, 2016-2025 (USD MILLION) 126

TABLE 52 NORTH AMERICA BIO IMPLANT MARKET, CLINICS, BY REGION, 2016-2025 (USD MILLION) 127

TABLE 53 NORTH AMERICA BIO IMPLANT MARKET, HOSPITALS, BY REGION, 2016-2025 (USD MILLION) 128

TABLE 54 NORTH AMERICA BIO IMPLANT MARKET, AMBULATORY SURGICAL CENTERS, BY REGION, 2016-2025 (USD MILLION) 129

TABLE 55 NORTH AMERICA BIO IMPLANT MARKET, OTHERS, BY REGION, 2016-2025 (USD MILLION) 130

TABLE 56 NORTH AMERICA BIO-IMPLANTS MARKET, BY COUNTRY, 2016-2025 (USD MILLION) 138

TABLE 57 NORTH AMERICA BIO-IMPLANTS MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 139

TABLE 58 NORTH AMERICA BIO-IMPLANTS MARKET, ORTHOPEDICS & TRAUMA, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 140

TABLE 59 NORTH AMERICA BIO-IMPLANTS MARKET, RECONSTRUCTIVE JOINT REPLACEMENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 140

TABLE 60 NORTH AMERICA BIO-IMPLANTS MARKET, EXTREMITIES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 141

TABLE 61 NORTH AMERICA BIO-IMPLANTS MARKET, ORTHOBIOLOGICS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 141

TABLE 62 NORTH AMERICA BIO-IMPLANTS MARKET, TRAUMA IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 142

TABLE 63 NORTH AMERICA BIO-IMPLANTS MARKET, PACING DEVICES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 142

TABLE 64 NORTH AMERICA BIO-IMPLANTS MARKET, IMPLANTABLE CARDIAC PACEMAKERS (ICPS), BY PRODUCT TYPE, 2016-2025 (USD MILLION) 143

TABLE 65 NORTH AMERICA BIO-IMPLANTS MARKET, PACING ACCESSORIES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 143

TABLE 66 NORTH AMERICA BIO-IMPLANTS MARKET, STENTS & RELATED IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 144

TABLE 67 NORTH AMERICA BIO-IMPLANTS MARKET, CORONARY STENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 144

TABLE 68 NORTH AMERICA BIO-IMPLANTS MARKET, PERIPHERAL STENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 145

TABLE 69 NORTH AMERICA BIO-IMPLANTS MARKET, STENT-RELATED IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 145

TABLE 70 NORTH AMERICA BIO-IMPLANTS MARKET, SPINAL IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 146

TABLE 71 NORTH AMERICA BIO-IMPLANTS MARKET, OPHTHALMIC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 146

TABLE 72 NORTH AMERICA BIO-IMPLANTS MARKET, STRUCTURAL CARDIAC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 147

TABLE 73 NORTH AMERICA BIO-IMPLANTS MARKET, DENTAL IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 147

TABLE 74 NORTH AMERICA BIO-IMPLANTS MARKET, NEUROSTIMULATORS IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 148

TABLE 75 NORTH AMERICA BIO-IMPLANTS MARKET, PROSTHETIC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 148

TABLE 76 NORTH AMERICA BIO-IMPLANTS MARKET, OTHERS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 149

TABLE 77 NORTH AMERICA BIO-IMPLANTS MARKET, BY TYPE, 2016-2025 (USD MILLION) 150

TABLE 78 NORTH AMERICA BIO-IMPLANTS MARKET, BY MATERIAL, 2016-2025 (USD MILLION) 150

TABLE 79 NORTH AMERICA BIO-IMPLANTS MARKET, BIOMATERIAL METAL, BY TYPE, 2016-2025 (USD MILLION) 151

TABLE 80 NORTH AMERICA BIO-IMPLANTS MARKET, POLYMERS, BY TYPE, 2016-2025 (USD MILLION) 151

TABLE 81 NORTH AMERICA BIO-IMPLANTS MARKET, BY MODE OF ADMINISTRATION, 2016-2025 (USD MILLION) 152

TABLE 82 NORTH AMERICA BIO-IMPLANTS MARKET, NON-SURGICAL, BY MODE OF ADMINISTRATION, 2016-2025 (USD MILLION) 152

TABLE 83 NORTH AMERICA BIO-IMPLANTS MARKET, BY END USER, 2016-2025 (USD MILLION) 153

TABLE 84 U.S. BIO-IMPLANTS MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 154

TABLE 85 U.S. BIO-IMPLANTS MARKET, ORTHOPEDICS & TRAUMA, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 155

TABLE 86 U.S. BIO-IMPLANTS MARKET, RECONSTRUCTIVE JOINT REPLACEMENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 155

TABLE 87 U.S. BIO-IMPLANTS MARKET, EXTREMITIES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 156

TABLE 88 U.S. BIO-IMPLANTS MARKET, ORTHOBIOLOGICS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 156

TABLE 89 U.S. BIO-IMPLANTS MARKET, TRAUMA IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 157

TABLE 90 U.S. BIO-IMPLANTS MARKET, PACING DEVICES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 157

TABLE 91 U.S. BIO-IMPLANTS MARKET, IMPLANTABLE CARDIAC PACEMAKERS (ICPS), BY PRODUCT TYPE, 2016-2025 (USD MILLION) 158

TABLE 92 U.S. BIO-IMPLANTS MARKET, PACING ACCESSORIES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 158

TABLE 93 U.S. BIO-IMPLANTS MARKET, STENTS & RELATED IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 159

TABLE 94 U.S. BIO-IMPLANTS MARKET, CORONARY STENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 159

TABLE 95 U.S. BIO-IMPLANTS MARKET, PERIPHERAL STENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 160

TABLE 96 U.S. BIO-IMPLANTS MARKET, STENT-RELATED IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 160

TABLE 97 U.S. BIO-IMPLANTS MARKET, SPINAL IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 161

TABLE 98 U.S. BIO-IMPLANTS MARKET, OPHTHALMIC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 161

TABLE 99 U.S. BIO-IMPLANTS MARKET, STRUCTURAL CARDIAC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 162

TABLE 100 U.S. BIO-IMPLANTS MARKET, DENTAL IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 162

TABLE 101 U.S. BIO-IMPLANTS MARKET, NEUROSTIMULATORS IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 163

TABLE 102 U.S. BIO-IMPLANTS MARKET, PROSTHETIC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 163

TABLE 103 U.S. BIO-IMPLANTS MARKET, OTHERS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 164

TABLE 104 U.S. BIO-IMPLANTS MARKET, BY TYPE, 2016-2025 (USD MILLION) 165

TABLE 105 U.S. BIO-IMPLANTS MARKET, BY MATERIAL, 2016-2025 (USD MILLION) 165

TABLE 106 U.S. BIO-IMPLANTS MARKET, BIOMATERIAL METAL, BY TYPE, 2016-2025 (USD MILLION) 166

TABLE 107 U.S. BIO-IMPLANTS MARKET, POLYMERS, BY TYPE, 2016-2025 (USD MILLION) 166

TABLE 108 U.S. BIO-IMPLANTS MARKET, BY MODE OF ADMINISTRATION, 2016-2025 (USD MILLION) 167

TABLE 109 U.S. BIO-IMPLANTS MARKET, NON-SURGICAL, BY MODE OF ADMINISTRATION, 2016-2025 (USD MILLION) 167

TABLE 110 U.S. BIO-IMPLANTS MARKET, BY END USER, 2016-2025 (USD MILLION) 168

TABLE 111 CANADA BIO-IMPLANTS MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 169

TABLE 112 CANADA BIO-IMPLANTS MARKET, ORTHOPEDICS & TRAUMA, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 170

TABLE 113 CANADA BIO-IMPLANTS MARKET, RECONSTRUCTIVE JOINT REPLACEMENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 170

TABLE 114 CANADA BIO-IMPLANTS MARKET, EXTREMITIES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 171

TABLE 115 CANADA BIO-IMPLANTS MARKET, ORTHOBIOLOGICS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 171

TABLE 116 CANADA BIO-IMPLANTS MARKET, TRAUMA IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 172

TABLE 117 CANADA BIO-IMPLANTS MARKET, PACING DEVICES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 172

TABLE 118 CANADA BIO-IMPLANTS MARKET, IMPLANTABLE CARDIAC PACEMAKERS (ICPS), BY PRODUCT TYPE, 2016-2025 (USD MILLION) 173

TABLE 119 CANADA BIO-IMPLANTS MARKET, PACING ACCESSORIES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 173

TABLE 120 CANADA BIO-IMPLANTS MARKET, STENTS & RELATED IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 174

TABLE 121 CANADA BIO-IMPLANTS MARKET, CORONARY STENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 174

TABLE 122 CANADA BIO-IMPLANTS MARKET, PERIPHERAL STENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 175

TABLE 123 CANADA BIO-IMPLANTS MARKET, STENT-RELATED IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 175

TABLE 124 CANADA BIO-IMPLANTS MARKET, SPINAL IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 176

TABLE 125 CANADA BIO-IMPLANTS MARKET, OPHTHALMIC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 176

TABLE 126 CANADA BIO-IMPLANTS MARKET, STRUCTURAL CARDIAC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 177

TABLE 127 CANADA BIO-IMPLANTS MARKET, DENTAL IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 177

TABLE 128 CANADA BIO-IMPLANTS MARKET, NEUROSTIMULATORS IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 178

TABLE 129 CANADA BIO-IMPLANTS MARKET, PROSTHETIC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 178

TABLE 130 CANADA BIO-IMPLANTS MARKET, OTHERS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 179

TABLE 131 CANADA BIO-IMPLANTS MARKET, BY TYPE, 2016-2025 (USD MILLION) 180

TABLE 132 CANADA BIO-IMPLANTS MARKET, BY MATERIAL, 2016-2025 (USD MILLION) 180

TABLE 133 CANADA BIO-IMPLANTS MARKET, BIOMATERIAL METAL, BY TYPE, 2016-2025 (USD MILLION) 181

TABLE 134 CANADA BIO-IMPLANTS MARKET, POLYMERS, BY TYPE, 2016-2025 (USD MILLION) 181

TABLE 135 CANADA BIO-IMPLANTS MARKET, BY MODE OF ADMINISTRATION, 2016-2025 (USD MILLION) 182

TABLE 136 CANADA BIO-IMPLANTS MARKET, NON-SURGICAL, BY MODE OF ADMINISTRATION, 2016-2025 (USD MILLION) 182

TABLE 137 CANADA BIO-IMPLANTS MARKET, BY END USER, 2016-2025 (USD MILLION) 183

TABLE 138 MEXICO BIO-IMPLANTS MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 184

TABLE 139 MEXICO BIO-IMPLANTS MARKET, ORTHOPEDICS & TRAUMA, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 185

TABLE 140 MEXICO BIO-IMPLANTS MARKET, RECONSTRUCTIVE JOINT REPLACEMENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 185

TABLE 141 MEXICO BIO-IMPLANTS MARKET, EXTREMITIES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 186

TABLE 142 MEXICO BIO-IMPLANTS MARKET, ORTHOBIOLOGICS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 186

TABLE 143 MEXICO BIO-IMPLANTS MARKET, TRAUMA IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 187

TABLE 144 MEXICO BIO-IMPLANTS MARKET, PACING DEVICES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 187

TABLE 145 MEXICO BIO-IMPLANTS MARKET, IMPLANTABLE CARDIAC PACEMAKERS (ICPS), BY PRODUCT TYPE, 2016-2025 (USD MILLION) 188

TABLE 146 MEXICO BIO-IMPLANTS MARKET, PACING ACCESSORIES, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 188

TABLE 147 MEXICO BIO-IMPLANTS MARKET, STENTS & RELATED IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 189

TABLE 148 MEXICO BIO-IMPLANTS MARKET, CORONARY STENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 189

TABLE 149 MEXICO BIO-IMPLANTS MARKET, PERIPHERAL STENTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 190

TABLE 150 MEXICO BIO-IMPLANTS MARKET, STENT-RELATED IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 190

TABLE 151 MEXICO BIO-IMPLANTS MARKET, SPINAL IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 191

TABLE 152 MEXICO BIO-IMPLANTS MARKET, OPHTHALMIC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 191

TABLE 153 MEXICO BIO-IMPLANTS MARKET, STRUCTURAL CARDIAC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 192

TABLE 154 MEXICO BIO-IMPLANTS MARKET, DENTAL IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 192

TABLE 155 MEXICO BIO-IMPLANTS MARKET, NEUROSTIMULATORS IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 193

TABLE 156 MEXICO BIO-IMPLANTS MARKET, PROSTHETIC IMPLANTS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 193

TABLE 157 MEXICO BIO-IMPLANTS MARKET, OTHERS, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 194

TABLE 158 MEXICO BIO-IMPLANTS MARKET, BY TYPE, 2016-2025 (USD MILLION) 195

TABLE 159 MEXICO BIO-IMPLANTS MARKET, BY MATERIAL, 2016-2025 (USD MILLION) 195

TABLE 160 MEXICO BIO-IMPLANTS MARKET, BIOMATERIAL METAL, BY TYPE, 2016-2025 (USD MILLION) 196

TABLE 161 MEXICO BIO-IMPLANTS MARKET, POLYMERS, BY TYPE, 2016-2025 (USD MILLION) 196

TABLE 162 MEXICO BIO-IMPLANTS MARKET, BY MODE OF ADMINISTRATION, 2016-2025 (USD MILLION) 197

TABLE 163 MEXICO BIO-IMPLANTS MARKET, NON-SURGICAL, BY MODE OF ADMINISTRATION, 2016-2025 (USD MILLION) 197

TABLE 164 MEXICO BIO-IMPLANTS MARKET, BY END USER, 2016-2025 (USD MILLION) 198

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Abbott Laboratories

Medtronic

Boston Scientific Corporation

Bio-Rad Laboratories, Inc.

Somnomed Limited

Johnson & Johnson Services, Inc.

Edwards Lifesciences Corporation

F. Hoffmann-La Roche AG

C.R. Bard, Inc.

Mimedx Group, Inc.

Biotronik Se & Co.Kg

chat_bubbleLet's Chat